IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#1576
Positioning
Market Dominance
Manufacturing
Machinery
$23M
Emmanuel Lakios
CVD Equipment Corporation designs, develops, manufactures, and sells process equipment and solutions. It operates through three segments: CVD, SDC, and CVD Materials. The company sells its products primarily to aerospace/defense, medical, electronic component manufacturers, universities, and government and industrial laboratories.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 32.9% | 20.5% | 48.8% | 30.6% | 24.4% | 7.7% | 0.9% | 32.0x | $148.6B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.4% | 7.5% | 68.3% | 19.5% | 18.2% | 29.0% | 0.0% | 0.0x | $84M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$CVV CVD EQUIPMENT CORP | 53 | 57 | 67 | 68 | 63.5x | 135.3x | -0.4% | -0.4% | 27.1% | -3.5% | -2.2% | 16.8% | 0.0% | 16.0x | $23M | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -1.9% | 0.9% | 44.1% | 2.5% | 1.0% | 6.7% | 0.0% | 0.2x | - | REF |
CVD EQUIPMENT CORP (CVV) receives a "Hold" rating with a composite score of 52.7/100. It ranks #1576 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
Outperforming peers — winners tend to keep winning over 3-12 months
Trading at a discount to fundamentals — favorable entry valuation
Average quality profile
Average volatility — neutral timing signal
Moderate investment profile
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for CVV.
View All Ratings| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 57 | 58 | -1NEUTRAL |
| MOMENTUM | 68 | 71 | -3NEUTRAL |
| VALUATION | 67 | 65 | +2NEUTRAL |
| INVESTMENT | 37 | 69 | -32DRAG |
| STABILITY | 44 | 34 | +10ALPHA |
| SHORT INT | 51 | 56 | -5NEUTRAL |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy -0.4% (sector -1.9%)
GM 27% vs sector 44%, OM -3% vs sector 3%
Capital turnover N/A, R&D intensity 9.9%
Rev growth 17%, 10yr history
Interest coverage 102.7x, Net debt/EBITDA -17.3x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
We rate CVD EQUIPMENT CORP (CVV) as a Hold with a composite score of 52.7/100 at a current price of $3.99. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling.
CVD EQUIPMENT CORP holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 52.7/100 places it at rank #1576 in our full universe.
The near-term outlook is constructive, with revenue growing at 17% and momentum in the 68th percentile confirming positive market sentiment. The combination of strong top-line growth and favorable price dynamics suggests the company is executing well on its growth strategy.
No Moat
High
Poor
Undervalued
Value factor score of 67 suggests attractive pricing.
Positive momentum indicates institutional accumulation.
Stable competitive position in a defensive sector.
Elevated P/E ratio of 63.5x leaves little room for execution misses.
Vulnerability to macroeconomic shocks and interest rate volatility.
CVD EQUIPMENT CORP represents a hold based on multi-factor quantitative performance.
Our model assigns CVD EQUIPMENT CORP a Hold rating, with a composite score of 52.7/100 and 3 out of 5 stars. Ranked #1576 of 7,333 stocks, CVV presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
With a quality score of 57/100, CVV shows adequate but unremarkable business quality. The company reports a return on equity of -0.4% (sector avg: -1.9%), gross margins of 27.1% (sector avg: 44.1%), net margins of -2.2% (sector avg: 1.0%). This suggests the company generates acceptable returns but may lack the competitive positioning or operational efficiency to stand out from peers.
CVV's value score of 67/100 indicates the stock is fairly valued based on its current fundamentals. Key valuation metrics include a P/E ratio of 63.50x, an EV/EBITDA of 135.28x, a P/B ratio of 1.05x. At this level, neither a clear bargain nor overpriced, the stock's attractiveness depends more on forward growth expectations and qualitative factors.
CVD EQUIPMENT CORP's investment score of 37/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 16.8% vs. a sector average of 6.7% and a return on assets of -0.4% (sector: 0.9%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
CVV demonstrates moderate momentum with a score of 68/100, suggesting a neutral price trend without strong directional conviction. Revenue growth stands at 16.8% year-over-year, while a beta of 0.98 reflects its sensitivity to broader market moves. Moderate momentum may indicate the stock is consolidating or transitioning between trends, warranting close monitoring of upcoming catalysts.
CVV's stability score of 44/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of 0.98 and a debt-to-equity ratio of 16.00x (sector avg: 0.2x). Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
The short interest score of 51/100 for CVV suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include elevated leverage (D/E: 16.00x), micro-cap liquidity risk. With a $23M market cap (micro-cap), CVD EQUIPMENT CORP may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
CVD EQUIPMENT CORP is a micro-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #1576 of 7,333 overall (79th percentile). Key comparisons include ROE of -0.4% exceeding the -1.9% sector median and operating margins of -3.5% below the 2.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While CVV currently exhibits a HOLD profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Upgrade catalyst
Investment (37) is the limiting factor — improvement here would lift the composite score most.
EV/EBITDA 1080% ABOVE SECTOR MEDIAN
ROE 77% BELOW SECTOR MEDIAN
Gross Margin 38% BELOW SECTOR MEDIAN
Above 50MA
37.18%
Net New Highs
+51081
CVD Equipment Corporation ( NASDAQ:CVV ) shareholders have had their patience rewarded with a 36% share price jump in...
Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares jumped 120% to $0.33. Timber Pharmaceuticals, Inc. (NYSE: TMBR) gained 97.1% to $2.7993 as the company agreed to be acquired by LEO US Holding, Inc., a wholly-owned subsidiary of LEO Pharma A/S, for a total transaction value of $36 million.. MediaCo Holding Inc. (NASDAQ: MDIA) jumped 38.5% to $0.79. Novo Integrated Sciences, Inc. (NASDAQ: NVOS) gained 39% to $0.1849. Tian Ruixiang Holdings Ltd (NASDAQ: TIRX) shares surged 34.2% to $1.45. Fresh Vine Wine, Inc. (NYSE: VINE) gained 32% to $0.41. China Pharma Holdings, Inc. (NYSE: CPHI) climbed 26.5% to $0.2771. STRATA Skin Sciences, Inc. (NASDAQ: SSKN) surged 24.1% to $0.7829. Genius Group Limited (NYSE: GNS) shares climbed 22.2% to $1.4414 after jumping 19% on Friday. The Growth for Good Acquisition Corporation (NASDAQ: GFGD) shares gained 21.6% to $10.29 in pre-market trading. The Growth for Good Acquisition Corporation announced postponement of its extraordinary general meeting of shareholders and extension of redemption date. Kingstone Companies, Inc. (NASDAQ: KINS) surged 21.3% to $1.65. BioNexus Gene Lab Corp. (NASDAQ: BGLC) gained 21.2% to $1.03. Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) surged 20.4% to $6.41. CVD Equipment Corporation (NASDAQ: CVV) jumped 20% to $6.60. Tupperware Brands Corporation (NYSE: TUP) surged 18% to $2.9194. Applied Optoelectronics, Inc. (NASDAQ: AAOI) climbed 18% to $15.11. Applied Optoelectronics Form 4 Filing showed President and CEO Lin Chih-Hsiang (Thompson) bought 20,000 shares at an average price of $12.38/share. BTC Digital Ltd. (NASDAQ: METX) gained 17.3% to $0.1994. VinFast Auto Ltd. (NASDAQ: VFS) ...
Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering. The Singing Machine Company, Inc. (NASDAQ: MICS) surged 73% to $1.81 after the company announced termination of its at-the-market equity program. Applied Digital Corporation (NASDAQ: APLD) gained 44.6% to $4.94 after the company announced that its recently launched AI Cloud Service has secured its first major AI customer with an agreement worth up to $180 million over a 24-month period. OncoSec Medical Incorporated (NASDAQ: ONCS) jumped 30% to $1.08. OncoSec said Type C meeting with the FDA was held on May 15. Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) gained 27.6% to $4.88. Cyclerion reported a 1-for-20 reverse stock split, effective 5 p.m. on May 15. Phio Pharmaceuticals Corp. (NASDAQ: PHIO) jumped 24.4% to $4.18 after the company announced the FDA cleared its Investigational New Drug application to proceed with a clinical trial of its lead product candidate, PH-762. Blue Apron Holdings, Inc. (NYSE: APRN) jumped 25% to $0.5726. Blue Apron announced plans to shift to an asset-light model through the transfer of operational infrastructure to FreshRealm. VivoPower International PLC (NASDAQ: VVPR) shares gained 21.3% to $0.5631 after the company announced a definitive distribution agreement to distribute EV fleet charging solutions. Navitas Semiconductor Corporation (NASDAQ: NVTS) jumped 18.8% to $7.89 after the company reported better-than-expected Q1 financial results. Atlas Lithium Corporation (NASDAQ: ATLX) shares gained 18% to $22.39. United Insurance Holdings Corp. (NASDAQ: UIHC) gained 17.8% to $4.82 after posting a profit for the first quarter. Troika Media Group, Inc. (NASDAQ: TRKA) jumped 17.7% to $0.2328 after the company reported revenue of $59.0 million and adjusted EBITDA of $1.5 million for the three months ended March 31, 2023. ASP Isotopes Inc. (NASDAQ: ASPI) shares gained 16.3% to $0.51 after declining around 7% on Monday. Troika Media Group, Inc. (NASDAQ: TRKA) shares rose 16.3% to $0.2302 after the company reported a rise in third-quarter sales. Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) gained 15.8% to $10.09. Top KingWin Ltd (NASDAQ: TCJH) gained 15% to $7.34. Nanobiotix S.A. (NASDAQ: NBTX) rose 13.2% to $5.31. Nanobiotix recently announced it is entering into final contract negotiations after agreement to a non-binding term ...
Gainers Broadwind Inc (NASDAQ: BWEN) shares climbed 85.4% to $4.19 after the company announced the receipt of approximately $175 million in new tower orders from a leading global wind turbine manufacturer. Lipella Pharmaceuticals Inc (NASDAQ: LIPO) gained 63.2% to $5.06 after the company announced top line results of its Phase 2a clinical trial evaluating the safety and efficacy of its drug candidate LP-10 for Hemorrhagic Cystitis. Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 53.1% to $3.17 after adding more than 27% during regular market hours on Tuesday. According to a Wall Street Journal report citing people familiar with the matter, Bed Bath & Beyond has brought on consulting firm AlixPartners as its new restructuring advisor. The company reported a quarterly adjusted net loss of $3.65 per share, which missed estimates for a loss of $2.11 per share. Laser Photonics Corporation (NASDAQ: LASE) rose 42.3% to $3.60. Laser Photonics said on Jan. 9, that the company’s board authorized initiation of share repurchase program to purchase up to 2 million shares of common stock. Avaya Holdings Corp. (NYSE: AVYA) jumped 40% to $0.2948. Ontrak, Inc. (NASDAQ: OTRK) gained 36% to $0.6122. Inotiv Inc (NASDAQ: NOTV) shares gained 30.4% to $7.29 after the company reported better-than-expected Q4 EPS results. VerifyMe, Inc. (NASDAQ: VRME) jumped 26.6% to $1.5827. Tempest Therapeutics, Inc. (NASDAQ: TPST) gained 24.4% to $1.68. Werewolf Therapeutics, Inc. (NASDAQ: HOWL) climbed 23.3% to $2.7498. CVD Equipment Corporation (NASDAQ: CVV) jumped 21.9% to $7.51. Landos Biopharma, Inc. (NASDAQ: LABP) surged 20% to ...
Discover why Zacks rates CVD Equipment as "Underperform", being the first on Wall Street to initiate coverage on the stock. Explore CVV's supply-chain disruptions, financial health, and competitive pressures.